<p>Cost-Effectiveness of Ribociclib for Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost-Effectiveness of Ribociclib for Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer

Published:2020-12 Issue: Volume:Volume 12 Page:12905-12913
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Yang Jiangping,Han Jiaqi,Tian Maolang,Tian Kun,Liao Wenjun,Yan Xi

Publisher

Informa UK Limited

Subject

Oncology

Reference47 articles.

1. Cancer statistics, 2020

2. Breast Cancer Treatment

3. Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer

4. Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

5. Changing Concepts of Hormone Receptor–Positive Advanced Breast Cancer Therapy

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and economic outcomes of adding [18F]FES PET/CT in estrogen receptor status identification in metastatic and recurrent breast cancer in the US;PLOS ONE;2024-05-14

2. Is circulating tumor cell count-driven cost-effective for first-line therapy choice in HR+/HER2- metastatic breast cancer in the United States?;The Breast;2024-04

3. Is Alpelisib Plus Fulvestrant Cost-Effective for Treating PIK3CA-Mutation, HR+/HER2− Advanced Breast Cancer in the USA?;Clinical Drug Investigation;2023-11-17

4. Cost-effectiveness of Trastuzumab Deruxtecan for HER2-low Advanced Breast Cancer in the United States;Clinical Therapeutics;2023-10

5. Is adding ribociclib to fulvestrant cost-effective in treating postmenopausal women with HR+/HER2- advanced or metastatic breast cancer? A US payer perspective cost utility analysis;Journal of Managed Care & Specialty Pharmacy;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3